Alexandru Ionuț Ciobanu

Mr. Alexandru Ionuț Ciobanu

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Alexandru HerdeaAlexandru Herdea
Alexandru Herdea
ACAlexandru Ionuț Ciobanu
Alexandru Ionuț Ciobanu
Alexandru UliciAlexandru Ulici
Alexandru Ulici
Adolescent idiopathic scoliosis (AIS) is a three-dimensional deformity of the growing spine, frequently associated with functional impairment, altered trunk biomechanics, compromised respiratory performance, and psychosocial burden. The risk of curve progression increases during periods of rapid growth, highlighting the need for effective conservative interventions targeting both structural and neuromuscular components of the deformity. This review synthesizes evidence published between 2005 and 2025 on the effects of Schroth-based physiotherapeutic scoliosis-specific exercises in adolescents aged 10–18 years with idiopathic scoliosis and Risser stages 0–5. Studies applying Schroth therapy exclusively or predominantly, either as a stand-alone intervention or combined with bracing, were included, while non-idiopathic scoliosis and mixed PSSE protocols were excluded. A total of 17 studies meeting predefined eligibility criteria were included. Across randomized controlled trials, controlled cohort studies, and longitudinal case series, Schroth interventions were associated with attenuation of Cobb angle progression, improvements in three-dimensional trunk symmetry, postural control, respiratory mechanics, and health-related quality of life. Combined Schroth and brace therapy generally demonstrated superior outcomes compared with bracing alone. Despite these findings, heterogeneity in intervention protocols and outcome measures limits direct comparability across studies. Overall, current evidence supports the Schroth Method as a relevant conservative strategy for AIS, particularly when initiated early and delivered through individualized three-dimensional correction. Further high-quality multicenter studies with standardized protocols are required to strengthen the long-term evidence base.

15 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Alexandru UliciAlexandru Ulici
Alexandru Ulici
ACAlexandru Ionuț Ciobanu
Alexandru Ionuț Ciobanu
Alexandru HerdeaAlexandru Herdea
Alexandru Herdea
Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional spinal deformity with a substantial but incompletely understood genetic component. Advances in genomic research have shifted the genetic landscape of AIS from early candidate-gene associations toward reproducible genome-wide susceptibility loci, rare variants, and functionally relevant regulatory mechanisms. This review synthesizes current evidence across successive levels of AIS genetic investigation—from candidate-gene studies and genome-wide association studies to rare-variant analyses and functional genomics—and integrates these findings according to the biological pathways through which inherited variation may contribute to disease development. Rather than cataloguing individual susceptibility genes, the review specifically examines how genetic findings of different levels of evidence converge on interconnected developmental, cartilage, extracellular-matrix, hormonal/metabolic, and growth-related mechanisms. Genome-wide association studies have consistently implicated loci including LBX1, GPR126/ADGRG6, PAX1, and SOX6, supporting the involvement of developmental and musculoskeletal pathways. Rare-variant analyses and functional studies have further implicated extracellular-matrix pathways, including evidence involving COL11A1 and COL11A2. Collectively, current genetic evidence converges on interconnected processes involving neural and somitic development, chondrogenesis, extracellular-matrix organization and remodeling, hormonal and metabolic regulation, and skeletal growth. Functional evidence involving PAX1, GPR126/ADGRG6, and COL11A1 provides emerging mechanistic links between genetic variation and spinal development, although the biological consequences of many susceptibility loci remain unresolved. Current evidence supports AIS as a complex polygenic developmental disorder in which common variants, rare variants, and regulatory mechanisms collectively contribute to disease susceptibility. Future research should prioritize functional validation, multi-omics integration, gene–environment interactions, and large multi-ethnic cohorts to advance from genetic association toward a more comprehensive biological understanding of AIS pathogenesis.

14 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Alexandru UliciAlexandru Ulici
Alexandru Ulici
ACAlexandru Ionuț Ciobanu
Alexandru Ionuț Ciobanu
Alexandru HerdeaAlexandru Herdea
Alexandru Herdea
Adolescent idiopathic scoliosis (AIS) is characterized by substantial variability in curve progression and response to conservative treatment, making accurate prognostic assessment a major clinical challenge. Although established clinical and radiographic factors contribute to risk stratification, they do not fully explain individual differences in disease evolution or brace treatment outcome. This review critically examines current evidence on genetic determinants of curve progression and brace treatment response in AIS, with particular emphasis on their potential contribution to individualized risk prediction. Candidate-gene studies have reported associations involving hormonal, metabolic, developmental, and skeletal pathways, while studies of brace response have identified potential predictive associations involving ERα, TPH1, VDR, VDBP, and BNC2. Multigene approaches, including ScoliScore, have further explored the potential of polygenic information for prognostic assessment. However, reported genetic effects are generally modest, replication across populations remains limited, and substantial heterogeneity exists in study design, outcome definitions, and characterization of brace treatment. Importantly, current evidence remains insufficient to demonstrate clinically meaningful predictive value of genetic information beyond established clinical factors. Future research should prioritize large prospective multicenter cohorts, standardized definitions of progression and treatment outcome, objective assessment of brace adherence and correction, progression-specific polygenic approaches, and external validation across diverse populations. Ultimately, integrating genetic information with clinical, radiographic, developmental, biomechanical, and treatment-related variables may provide a more comprehensive framework for individualized prediction and precision management of AIS.